ENETS consensus guidelines for the standards of care in neuroendocrine tumors: Chemotherapy in patients with neuroendocrine tumors

Neuroendocrinology

Volumn 90, Issue 2, 2009, Pages 214-219

  Eriksson, Barbro ^a   Annibale, Bruno ^b   Bajetta, Emilio ^c   Mitry, Emmanuel ^d   Pavel, Marianne ^e   Platania, Marco ^c   Salazar, Ramon ^f   Plöckinger, Ursula ^e   Åkerström, Göran ^a   Arnold, Rudolf ^g   Barkmanova, Jaroslava ^h   Chen, Yuan Jia ⁱ   Costa, Frederico ^j   Couvelard, Anne ^k   Davar, Joseph ^l   De Herder, Wouter ^m   Delle Fave, Gianfranco ⁿ   Falconi, Massimo ^o   Ferone, Diego ^p   Gross, David ^q   Grossman, Ashley ^r   Gustafsson, Björn ^s   Hyrdel, Rudolf ^g   Ivan, Diana ^t   Kaltsas, Gregory ^u   Kianmanesh, Reza ^v   Klöppel, Günter ^w   Knigge, Ulrich Peter ^x   Komminoth, Paul ^y   Kos Kudła, Beata ^l   Kwekkeboom, Dik ^z   Lebtahi, Rachida ^aa   Lewington, Val ^ab   McNicol, Anne Marie ^ac   Nilsson, Ola ^a   Öberg, Kjell ^ad   O'Connor, Juan ^ae   O'Toole, Dermot ^e   Pape, Ulrich Frank ^af   Papotti, Mauro ^ag   Perren, Aurel ^ah   Rindi, Guido ^ah   Ruszniewski, Philippe ^ai   Scarpa, Aldo ^aj   Scheidhauer, Klemens ^ag   Scoazec, Jean Yves ^ak   Sundin, Anders ^a   Szpak, Waldemar ^al   Taal, Babs ^am   Vitek, Pavel ^h   Vullierme, Marie Pierre ^ai   Wiedenmann, Bertram ^e   more..

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c NATIONAL CANCER INSTITUTE   (Italy)

^d Hopital Univ Ambroise Pare   (France)

^e CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^f CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^g PHILIPPS UNIVERSITY MARBURG   (Germany)

^h CHARLES UNIVERSITY   (Czech Republic)

ⁱ PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^j HOSPITAL SÍRIO LIBANÊS   (Brazil)

^k ROYAL FREE HOSPITAL   (United Kingdom)

^l ERASMUS MEDICAL CENTER   (Netherlands)

^m SAPIENZA UNIVERSITY OF ROME   (Italy)

ⁿ UNIVERSITY OF VERONA   (Italy)

^o UNIVERSITY OF GENOA   (Italy)

^p HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^q ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^r TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^s Martinska Fakultna Nemocnica   (Slovakia)

^t G GENNIMATAS GENERAL HOSPITAL   (Greece)

^u HÔPITAL LOUIS MOURIER   (France)

^v TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^w International Center for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health   (Denmark)

^x Institute for Pathology   (Switzerland)

^y MEDICAL UNIVERSITY OF SILESIA   (Poland)

^z BICHAT HOSPITAL   (France)

^aa INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^ab GLASGOW ROYAL INFIRMARY   (United Kingdom)

^ac SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^ad INSTITUTO ALEXANDER FLEMING   (Argentina)

^ae ST JAMES S HOSPITAL   (Ireland)

^af UNIVERSITY OF TURIN   (Italy)

^ag TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^ah UNIVERSITY OF PARMA   (Italy)

^ai BEAUJON HOSPITAL   (France)

^aj UNIVERSITY OF VERONA   (Italy)

^ak EDOUARD HERRIOT HOSPITAL   (France)

^al Westville Hospital   (South Africa)

^am Netherlands Cancer Centre   (Netherlands)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CAPECITABINE; CARBAMAZEPINE; CIPROFLOXACIN; CISPLATIN; CLARITHROMYCIN; DACARBAZINE; DICLOFENAC; DISULFIRAM; DOXORUBICIN; DOXYCYCLINE; ERYTHROMYCIN; ETOPOSIDE; FLUOROURACIL; IMATINIB; KETOCONAZOLE; MICONAZOLE; OXALIPLATIN; PHENOBARBITAL; PHENYTOIN; STREPTOZOCIN; TEMOZOLOMIDE;

ALOPECIA; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CARDIOTOXICITY; CONFERENCE PAPER; DIARRHEA; DIET; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; HUMAN; HYPOTENSION; INFECTION; KIDNEY DISEASE; LIVER DISEASE; NAUSEA; NAUSEA AND VOMITING; NEPHROTOXICITY; NEUROENDOCRINE TUMOR; PATIENT INFORMATION; PHOTOSENSITIVITY; PRACTICE GUIDELINE; PREGNANCY; PRIORITY JOURNAL; STOMATITIS; THERAPY EFFECT;

ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; HUMANS; NEUROENDOCRINE TUMORS;

EID: 69749117558     PISSN: 00283835     EISSN: None     Source Type: Journal    
DOI: 10.1159/000225950     Document Type: Conference Paper

References (6)

1. Moertel CG, Lefkopoulo M, Lipsity S, et al: Streptozotocin-doxorubicin, streptozotocin-fluorouracil or chlorozotocin in the treatment of advanced islet-cell carcinoma. N Engl J Med 1992;326:519-523.
2. Eriksson B, Öberg K: An update of the medical treatment of malignant endocrine pancreatic tumors. Acta Oncol 1993;32:203-208. (Pubitemid 23188537)
3. Eriksson B, Skogseid B, Lundqvist G, et al: Medical treatment and long-term survival in a prospective study of 84 patients with endocrine pancreatic tumors. Cancer 1990;65:1883-1890. (Pubitemid 20147622)
4. Moertel CG, Kvols LK, O'Connell MJ, et al: Treatment of neuroendocrine carcinomas with combined etoposide and cisplatin. Evidence of major therapeutic activity in the anaplastic variants of these neoplasms. Cancer 1991;68:227-232.
5. Mitry E, Badin E, Ducreux M, Sabourin JC, et al: Treatment of poorly differentiated neuroendocrine tumors with etoposide and cisplatin. Br J Cancer 1999;81:1351-1355.
6. Altimari A, Badrinath K, Reisel H, et al: DTIC therapy in patients with malignant intraabdominal neuroendocrine tumors. Surgery 1987;102:1009-1017. (Pubitemid 18021039)